These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38828510)

  • 21. Relationship of Red Cell Volume Distribution Width and N-Terminal Pro-Brain Natriuretic Peptide with Severity and Prognosis of Patients with Acute Coronary Syndrome Receiving Percutaneous Coronary Intervention.
    Pan R
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Prognostic Value of Serum Levels of Heart-Type Fatty Acid Binding Protein and High Sensitivity C-Reactive Protein in Patients With Increased Levels of Amino-Terminal Pro-B Type Natriuretic Peptide.
    Jeong JH; Seo YH; Ahn JY; Kim KH; Seo JY; Kim MJ; Lee HT; Park PW
    Ann Lab Med; 2016 Sep; 36(5):420-6. PubMed ID: 27374706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NT-proBNP levels in patients with non-ST-segment elevation acute coronary syndrome.
    Castro LR; Alencar MC; Barbosa MM; Nunes Mdo C; Cardoso JR; Ribeiro AL
    Arq Bras Cardiol; 2011 Dec; 97(6):456-61. PubMed ID: 22030563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial.
    Sharma A; Vaduganathan M; Ferreira JP; Liu Y; Bakris GL; Cannon CP; White WB; Zannad F
    J Am Heart Assoc; 2020 Jan; 9(1):e012797. PubMed ID: 31902327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.
    Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Damman P; Tijssen JG; Pinto YM
    Heart; 2014 Jan; 100(2):115-25. PubMed ID: 24179162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide.
    Kavsak PA; Ko DT; Newman AM; Palomaki GE; Lustig V; MacRae AR; Jaffe AS
    Clin Chem; 2007 Dec; 53(12):2112-8. PubMed ID: 17932131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome.
    Widera C; Pencina MJ; Meisner A; Kempf T; Bethmann K; Marquardt I; Katus HA; Giannitsis E; Wollert KC
    Eur Heart J; 2012 May; 33(9):1095-104. PubMed ID: 22199121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of N-terminal pro-B-type natriuretic peptide in the prediction of outcomes in ST-elevation myocardial infarction complicated by cardiogenic shock.
    Sharma YP; Kanabar K; Santosh K; Kasinadhuni G; Krishnappa D
    Indian Heart J; 2020; 72(4):302-305. PubMed ID: 32861389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of N-terminal proB-type natriuretic peptide for early identification of myocardial infarction in patients with high-risk non-ST-elevation acute coronary syndromes.
    Riezebos RK; Laarman GJ; Tijssen JGP; Verheugt FWA
    Clin Chem Lab Med; 2011 Aug; 49(8):1359-1365. PubMed ID: 21692686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes undergoing left main percutaneous coronary intervention.
    Jaberg L; Toggweiler S; Puck M; Frank M; Rufibach K; Lüscher TF; Corti R
    Circ J; 2011; 75(11):2648-53. PubMed ID: 21891968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.
    Lindholm D; James SK; Bertilsson M; Becker RC; Cannon CP; Giannitsis E; Harrington RA; Himmelmann A; Kontny F; Siegbahn A; Steg PG; Storey RF; Velders MA; Weaver WD; Wallentin L;
    Clin Chem; 2017 Feb; 63(2):573-584. PubMed ID: 27932413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarker of Collagen Turnover (C-Terminal Telopeptide) and Prognosis in Patients With Non- ST -Elevation Acute Coronary Syndromes.
    Zelniker TA; Jarolim P; Scirica BM; Braunwald E; Park JG; Das S; Sabatine MS; Morrow DA
    J Am Heart Assoc; 2019 May; 8(9):e011444. PubMed ID: 31020897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incremental prognostic value of C-reactive protein and N-terminal proB-type natriuretic peptide in acute coronary syndrome.
    Kim H; Yang DH; Park Y; Han J; Lee H; Kang H; Park HS; Cho Y; Chae SC; Jun JE; Park WH
    Circ J; 2006 Nov; 70(11):1379-84. PubMed ID: 17062957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix metalloproteinase-2 predicts mortality in patients with acute coronary syndrome.
    Dhillon OS; Khan SQ; Narayan HK; Ng KH; Mohammed N; Quinn PA; Squire IB; Davies JE; Ng LL
    Clin Sci (Lond); 2009 Nov; 118(4):249-57. PubMed ID: 19583569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of GRACE Risk Stratification by N-Terminal Pro-B-type Natriuretic Peptide Combined With D-Dimer in Patients With Non-ST-Elevation Myocardial Infarction.
    Lu PJ; Gong XW; Liu Y; Tian FS; Zhang WJ; Liu YW; Yao ZH; Wang JX; Han P; Yang YN; Cui Z; Gao J
    Am J Cardiol; 2021 Feb; 140():13-19. PubMed ID: 33159905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Takotsubo cardiomyopathy has a unique cardiac biomarker profile: NT-proBNP/myoglobin and NT-proBNP/troponin T ratios for the differential diagnosis of acute coronary syndromes and stress induced cardiomyopathy.
    Fröhlich GM; Schoch B; Schmid F; Keller P; Sudano I; Lüscher TF; Noll G; Ruschitzka F; Enseleit F
    Int J Cardiol; 2012 Feb; 154(3):328-32. PubMed ID: 22044675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
    Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
    Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome.
    Khan SQ; Narayan H; Ng KH; Dhillon OS; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Clin Sci (Lond); 2009 Jun; 117(1):31-9. PubMed ID: 19170658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.
    Gravning J; Smedsrud MK; Omland T; Eek C; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Mørkrid L; Edvardsen T
    Am Heart J; 2013 May; 165(5):716-24. PubMed ID: 23622908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-terminal pro B-type natriuretic peptide identifies patients with chest pain at high long-term cardiovascular risk.
    van der Zee PM; Cornel JH; Bholasingh R; Fischer JC; van Straalen JP; De Winter RJ
    Am J Med; 2011 Oct; 124(10):961-9. PubMed ID: 21962317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.